检索

期
标题
作者
卷 81, 编号 9 (2009)
Risk of cardiovascular complications in patients with frequent hypertensive crises
Kolos I., Chazova I., Tereshchenko S., Nakonechnikov S., Kolos I., Chazova I., Tereschenko S., Nakonechnikov S.
卷 80, 编号 8 (2008)
Chronic obstructive pulmonary disease and associated illnesses
Chuchalin A.
卷 79, 编号 10 (2004)
Use of alpha-adrenoblockers intherapy of benign prostatic hyperplasia in patients with arterial hypertension
Mazo E., Shashin M.
卷 79, 编号 6 (2004)
Blockers of angiotensin receptors: a novel approach to treatment of secondary pulmonary hypertension
Butorov I., Verbitsky О., Butorov S.
卷 79, 编号 3 (2004)
Markers of thrombophilia in pulmonary fibrosis complicated by pulmonary hypertension
Arkhipova D., Privalova E., Kozlovskaya L., Kornev B., Popova E., Kraeva V., Osipenko V., Bitsadze V.
卷 78, 编号 12 (2003)
The state of theleft ventricle of the heart and 24-h profile of arterial pressure in patients with effort angina and episodes of painlessmyocardial ischemia
Mazur E., Mazur V., Tkhind В., Omar I.
卷 78, 编号 3 (2003)
Role of some neurohumoral factors in the development of pulmonary hypertension in patients with interstitial Jung diseases
Arkhipova D., Kornev B., Popova E., Kogan E., Osipenko V., Privalova E., Kobylensky A., Mescheryakova S., Efremov E.
卷 78, 编号 8 (2003)
Efficacy and safetyof different p-blockers in patients with isolated systolic hypertension, associated with diabetes mellitus and obstructive pulmonary diseases
Kukes V., Ostroumova O., Mamaev V., Batutina A., Abakumov Y., Zykova A.
卷 90, 编号 9 (2018)
Arterial hypertension in the light of current recommendations
Chazova I.
PDF
(Rus)
卷 89, 编号 12 (2017)
Melatonin and hypertension: a possible role in combination therapy
Budnevsky A., Ovsyannikov E., Rezova N., Shkatova Y.
卷 89, 编号 3 (2017)
Pharmacoeconomic aspects of macitentan in the therapy of pulmonary arterial hypertension
Moisseeva O., Rudakova A.
PDF
(Rus)
卷 88, 编号 9 (2016)
Analysis of the management of hypertension complications in patients during emergency care
Alpysova A., Subbota Y., Adambekova A., Telembetov N., Maratkyzy M.
PDF
(Rus)
卷 87, 编号 12 (2015)
Hypertension and cognitive impairments: Possible mechanisms of development, diagnosis, and approaches to therapy
Zueva I.
卷 87, 编号 3 (2015)
Optimization of treatment in hypertensive patients in real clinical practice: Role of a fixed-dose perindopril A and amlodipine combination (Results of the Russian observational CONSTANTA trial)
Kobalava Z., Kotovskaya Y., Khodorovich N.
卷 86, 编号 9 (2014)
Principles of choice of an angiotensin-converting enzyme inhibitor: Specific features of perindopril
Morozova T., Gontarenko S., Kuz'mina E.
卷 86, 编号 9 (2014)
Clinical guidelines for the diagnosis and treatment of pulmonary hypertension
Chazova I., Avdeev S., Tsareva N., Volkov A., Martyniuk T., Nakonechnikov S.
卷 85, 编号 9 (2013)
What is the optimal choice of antihypertensive therapy based on: the class-specific effects or special properties of a drug?
Adasheva T., Samorukova E., Zadionchenko V., Nesterenko O.
卷 85, 编号 9 (2013)
On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (Exforge - Clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)
Chazova I., Martyniuk T.
卷 85, 编号 1 (2013)
Results of implementation of a hypertension control program in Russia in 2002-2012
Chazova I., Oshchepkova E.
卷 84, 编号 8 (2012)
Experience with ebrantil used in patients with resistant arterial hypertension in chronic kidney disease
Semenova R., Musina N.
卷 84, 编号 1 (2012)
New guidelines for hypertension in Russia - a priority of combined treatment
Karpov Y., Karpov Y.
卷 83, 编号 9 (2011)
High arterial rigidity is a significant but not obligatory factor of arterial hypertension in persons over 60 years of age
Boytsov S., Rogoza A., Kanishcheva E., Luk'yanov M., Boitsov S., Rogoza A., Kanischeva E., Lukianov M.
卷 82, 编号 9 (2010)
Renin inhibitors are a new direction in the treatment of arterial hypertension
Vasyuk Y., Sadulaeva I., Yushchuk E., Trofimenko O., Chirkov M., Fedoseeva V., Kulikov K., Vasyuk Y., Sadulayeva I., Yushchuk E., Trofimenko O., Chirkov M., Fedoseyeva V., Kulikov K.
卷 82, 编号 4 (2010)
Tissue myocardial Doppler echocardiographic evaluation of right heart function and the level natriuretic peptides in patients with pulmonary hypertension of various etiologies
Andreeva Y., Saidova M., Martynyuk T., Masenko V., Chazova I., Andreeva Y., Saidova M., Martynyuk T., Masenko V., Chazova I.
卷 81, 编号 8 (2009)
Renin as a target of direct pharmacological block in arterial hypertension
Mukhin N., Fomin V., Mukhin N., Fomin V.
卷 80, 编号 5 (2008)
Arterial hypertension and systemic inflammatory process: current status
Shilkina N., Iunonin I., Stoliarova S., Mikhaĭlova É.
卷 79, 编号 11 (2004)
Arterial hypertension in adolescents with different physical constitution including those with signs of metabolic syndrome
Rovda Y., Kazakova L., Rovda T., Rovda E.
卷 79, 编号 6 (2004)
Peculiarity of hypotensive efficacy in hypertensive patients with desaturation signs of obstructive sleep apnea syndrome
Zelveian I., Oschepkova E., Buniatian M., Rogoza A.
卷 78, 编号 12 (2003)
Microalbuminuria: clinical and prognostic value in arterial hypertension
Arakelyants A., Zhukova N., Ryazanov A., Yurenev A.
卷 78, 编号 10 (2003)
Gestational arterial hypertension.Mechanisms of formation.Treatment with normodipin
Davidovich I., Bloschinskaya I., Petrichko T.
卷 78, 编号 3 (2003)
Clinical and functional assessment of daily blood pressure variations in patients with pneumonia
Geltser B., Kolelnikov V., Brodskaya T.
卷 96, 编号 7 (2024): Vario (various)
Diagnosis and management of patients with pheochromocytoma/paraganglioma: Consensus of experts of the Russian Medical Society for Arterial Hypertension and the Multidisciplinary Group for the Diagnosis and Treatment of Neuroendocrine Tumors
Blinova N., Ilovayskaya I., Chikhladze N., Lugovskaya A., Britvin T., Gurevich L., Nefedova L., Shikina V., Chazova I.
PDF
(Rus)
卷 94, 编号 1 (2022)
Treatment of patients with arterial hypertension in clinical practice in 2010–2020 (according to the national register of hypertension)
Aksenova A., Oschepkova E., Chazova I.
PDF
(Rus)
卷 78, 编号 8 (2003)
Diroton effects on 24-h fluctuations of arterial pressure as shown bymonitoring in hypertensive patients with polycythemia vera
Gorokhovskaya G., Zavyalova A., Martynov A.
卷 91, 编号 1 (2019)
Comorbidity and polymorbidity of the patient with chronic obstructive pulmonary disease and cardiovascular diseases
Grigoryeva N., Maiorova M., Korolyova M., Samolyuk M.
PDF
(Rus)
卷 89, 编号 12 (2017)
Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension
Khadartsev A., Logatkina A., Terekhov I., Bondar S., Bondar N.
卷 89, 编号 2 (2017)
Pathogenetic bases and efficacy of slow calcium channel blockers in the therapy of recurrent peptic ulcer disease associated with hypertension
Fomina L., Chernin V.
PDF
(Rus)
卷 88, 编号 9 (2016)
Association of the -844G>A polymorphism in the catalase gene with the increased risk of essential hypertension in smokers
Bushueva O., Ivanov V., Ryzhaeva V., Ponomarenko I., Churnosov M., Polonikov A.
PDF
(Rus)
卷 87, 编号 11 (2015)
Survival in pulmonary arterial hypertension, associated with connective tissue diseases, treated by sildenafil: results of the prospective study
Volkov A., Nikolaeva E., Yudkina N., Kurmukov I., Nasonov E.
卷 87, 编号 4 (2015)
Cerebrovascular reactivity in patients with rheumatoid arthritis concurrent with and without hypertension
Rebrova N., Anisimova E., Sarkisova O., Mordovin V., Karpov R., Ripp T., Trifonova T., Bogomolova I.
卷 86, 编号 12 (2014)
Estimation of central blood pressure and arterial stiffness in pregnant women with different forms of hypertension
Chulkov V., Vereina N., Sinitsyn S., Dolgushina V.
卷 86, 编号 6 (2014)
Clinical value of the determination of markers for endothelial dysfunction (endothelin-1, microalbuminuria) and tubulointerstitial tissue lesion (Β2-microglobulin, monocyte chemotactic protein-1) in hypertensive patients with uric acid metabolic disorders
Stakhova T., Shcherbak A., Kozlovskaia L., Taranova M., Balkarov I.
卷 85, 编号 9 (2013)
The specific features of hypertension and the choice of treatment policy in old women
Podzolkov V., Bragina A., Nikitina T.
卷 85, 编号 5 (2013)
Problem of a comorbidity of arterial hypertension and acid-dependent diseases
Khlynova O., Tuev A., Beresneva L., Agafonov A.
卷 84, 编号 10 (2012)
Blood pressure variability and risk for complications in arterial hypertension
Ostroumova O.
卷 84, 编号 1 (2012)
Hypertension in pregnant women - a novel cardiorenal continuum
Gaysin I., Gaisin I.
卷 83, 编号 5 (2011)
Efficacy of combined treatment of patients with severe obstructive sleep apnea and arterial hypertension of the second and third degree
Sukmarova Z., Litvin A., Chazova I., Rogoza A., Sukmarova Z., Litvin A., Chazova I., Rogoza A.
卷 82, 编号 9 (2010)
Determinants of the respiratory system in hypertensive disease
Smakotina S., Bazdyrev E., Rutkovskaya N., Barbarash O., Smakotina S., Bazdyrev E., Rutkovskaya N., Barbarash O.
卷 81, 编号 10 (2009)
Essential hypertension, dementia, and antihypertensive therapy in geriatric patients
Kobalava Z., Kotovskaya Y., Tyul'kina E., Kobalava Z., Kotovskaya Y., Tyulkina E.
卷 81, 编号 6 (2009)
Neurohumoral regulation of blood pressure in rheumatic patients
Shilkina N., Stolyarova S., Yunonin I., Dryazhenkova I., Shilkina N., Stolyarova S., Dryazhenkova I.
51 - 100 的 206 信息 << < 1 2 3 4 5 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语